Karen Prange has an estimated net worth of $9.79 Million. This is based on reported shares across multiple companies, which include Embecta Corp., BOSTON SCIENTIFIC CORP, HENRY SCHEIN INC, ViewRay, Inc., AtriCure, Inc., NEVRO CORP, CANTEL MEDICAL CORP, and Outset Medical, Inc..

2016 was Karen Prange's most active year for acquiring shares with 9 total transactions. Karen Prange's most active month to acquire stocks was the month of January. 2016 was Karen Prange's most active year for disposing of shares, totalling 11 transactions. Karen Prange's most active month to dispose stocks was the month of January. 2022 saw Karen Prange paying a total of $100,001.50 for 105,854 shares, this is the most they've acquired in one year. In 2015 Karen Prange cashed out on 63,370 shares for a total of $553,785.20, their largest year based on trade value.